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ABSTRACT 
Background Most validations of paediatric glomernlar filtration rate (GFR) estimating equations using standardized 
ceatinine (CR) and cystatin C (CYS) assays have comprised relatively small cohorts, which makes accuracy across 
subgroups of GFR, age, body mass index (BMI) and gender uncertain. To overcome this, a large cohort of children 
referred for GFR determination has been established from several European medical centres. 
Methods Three thousand four hundred eight measurements of GFR (mGFR) using plasma clearance of exogenous 
substances were performed in 2218 children aged 2-17 years. Validated equations included Schwartz-
2009CR/2012CR/CYS/CR+CYS, FASCR/CYS/CR+CYS, LMRCR, Schwartz-LyonCR, BergCYS, CAPACYS, CKD-EPICYS, AndersenCR+CYS and 
arithmetic means of the best single-marker equations in explorative analysis. Five metrics were used to compare 
the performance of the GFR equations: bias, precision and three accuracy measures including the percentage of GFR 
estimates (eGFR) within ± 10% (P10) and ± 30% (P30) of mGFR. 
Results Three of the cystatin C equations, BergCYS, CAPACYS and CKD-EPICYS, exhibited low bias and generally 
satisfactory accuracy across all levels of mGFR; CKD-EPICYS had more stable performance across gender than the two 
other equations. Among creatinine equations, Schwartz-LyonCR had the best performance but was inaccurate at 
mGFR < 30 mL/min/1.73 m2 and in underweight patients. Arithmetic means of the best creatinine and cystatin C 
equations above improved bias compared to the existing composite creatinine+cystatin C equations. 
Conclusions The present study strongly suggests that cystatin C should be the primary biomarker of choice when 
estimating GFR in children with decreased GFR. Arithmetic means of well-performing single-marker equations 
improve accuracy further at most mGFR levels and have practical advantages compared to composite equations. 
Electronic supplementary material The online version of this article (https://doi.org/10.1007/s00467-018-4185-y) 
contains supplementary material, which is available to authorized users. 
 
Introduction 
Accurate assessment of glomerular filtration rate (GFR) in children is essential for correct classification and 
management of chronic kidney disease (CKD) and for adjusting drug dosage to avoid toxic effects from certain 
cytostatic drugs, antibiotics and radiographic contrast media. Measuring GFR (mGFR) in terms of clearance of 
exogenous substances is relatively costly, inconvenient in daily clinical practice and even unavailable in many 
hospitals, making equations based on plasma/serum concentrations of creatinine or cystatin C to estimate GFR 
(eGFR) a necessary alternative to evaluate renal function in many situations. 
Most validation studies regarding paediatric GFR equations based on standardized creatinine and cystatin C assays 
have been small, typically with fewer than 400 GFR measurements and with small numbers of patients with 
decreased GFR [1-13]. Therefore, the accuracy of even commonly used GFR equations in clinical practice is largely 
unknown across subgroups of GFR, age, body mass index (BMI) and sex. 
The aim of the present study was to validate commonly used GFR equations calibrated to International Federation 
of Clinical Chemistry and Laboratory Medicine (IFCC)- standardized creatinine and cystatin C assays in a large 
cohort of children pooled from several medical centres across Europe. 
Material and methods  
DATA SOURCES AND PARTICIPANTS 
A new European work group named “European Kidney Function Consortium” (EKFC) has recently been set up at 
two meetings (Malmö on September 25, 2017 and Copenhagen on May 26, 2018). EKFC took the initiative to collect 
retrospective data on subjects referred for GFR measurement including sCr, sCys, age, sex, height and weight. For 
this study, we selected a subset of all available data from this database, restricted to children 2 to 17 full years of 
age. Five different cohorts (see descriptions in Supplementary Material including Table S1) used in ongoing or 
published cross-sectional studies between 2004 and 2016 were included from the Netherlands (Amsterdam [7, 14-
17]), Belgium (Leuven [13]), France (Lyon [12, 13]) and Sweden (Lund [7] and Stockholm). Common reasons for 
determination of mGFR were congenital malformations, hereditary disorders, glomerulopathies, tubular diseases, 
vascular disorders, malignancies, urinary tract infections, liver diseases, transplantation follow-up and to dose 
drugs cleared by the kidneys. A study database, fully anonymous and without personal information, was pooled and 
centralized for the present study at Lund University, Sweden, comprising 3408 measurements of GFR in 2218 
children with complete data on sCr, sCys, age, gender, height and weight. All procedures involving subjects and data 
agreed with the ethical principles for medical research involving human subjects established in the World Medical 
Association Declaration of Helsinki of 1975, as revised in 2000. The study was reviewed and approved by the 
Regional Ethical Board in Lund, Sweden. 
LABORATORY ASSAYS 
All centres used creatinine assays traceable to isotope dilution mass spectrometry (IDMS). The cystatin C assays 
were calibrated against the international cystatin C reference material, ERM-DA471/IFCC, except for Lyon before 
April 2011 where the values were multiplied by 1.11 [13] and for Amsterdam before December 2012 where the 
values were multiplied by 1.174 [18] for conversion. For the data originating from the Caucasian, Asian, Paediatric 
and Adult (CAPA) cohort (Lund and part of Amsterdam cohort), extra care was undertaken to assure that the 
cystatin C assay used was commutable with regard to the reference material [7]. All assays for cystatin C and creat-
inine for the CAPA cohort were run on the same instrument (Architect ci8200) at one laboratory (Uppsala 
University Hospital, Sweden). An external quality assessment system (Equalis AB, Sweden) was used to monitor 
these analyses as well as those from Stockholm. 
Details of clearance methods and creatinine and cystatin C assays used in Amsterdam, Leuven, Lund and Lyon have 
been published earlier (see references in Supplementary Material and Table S1), while unpublished techniques 
used in Stockholm are described in more detail in Supplementary Material. External quality control was provided 
by Equalis AB (Uppsala, Sweden, www.equalis.se/en) regarding the iohexol measurements in Lund and Stockholm. 
GFR EQUATIONS 
The following GFR equations were analyzed (for equation expressions, see Supplementary Material): 
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1. Creatinine-based, general-purpose équations: The Full Age Spectrum based on age (FAS-AgeCR) and height (FAS-
HtCR) [12, 13, 19] and the Lund-Malmo revised equation (LMRCR) [20], which was developed for adults but has 
also been validated in children [21] 
2. Creatinine-based, paediatric equations: Schwartz- 2009CR [1], Schwartz-2012CR [3] and Schwartz-LyonCR [4] 
3. Cystatin C-based, general-purpose equations: CAPACYS [7], FASCYS [13] and the Chronic Kidney Disease 
Epidemiology collaboration equation (CKD-EPICYS) [22], which was developed for adults but has also been 
validated in children [7] 
4. Cystatin C based, paediatric equations: BergCYS [9] and Schwartz-2012CYS [3]. For the latter, the cystatin C values 
were divided by 1.174 to make the equation suitable for cystatin C values compatible with the international 
calibrator [18] 
5. Composite creatinine and cystatin C-based, general- purpose equations: FAS-AgeCR+CYS and FAS-HtCR+CYS [13] 
6. Composite creatinine and cystatin C-based, paediatric equations: Schwartz-2012CR+CYS [3] and AndersenCR+ CYS 
[5], the latter with absolute values normalized to 1.73-m body surface area 
STATISTICAL EVALUATION 
All statistical evaluations were conducted using IBM SPSS Statistics (version 25; IBM Corp.), STATA (version 14.2; 
StataCorp), PROC QUANTREG in SAS 9.4, (SAS Institute Inc., Cary, NC, US) and Microsoft Excel (Microsoft 
Corporation, Redmond, WA, USA). Five performance metrics were used: 
Bias: Median individual differences eGFR - mGFR (mL/ min/1.73 m2) 
Precision: Interquartile range (IQR) of the differences eGFR - mGFR 
Accuracy: Median absolute percentage error (100 ∙|eGFR - mGFR| / mGFR) and the percentage of estimates 
within ±10 and ± 30 % of mGFR (labelled P10 and P30). P30 accuracy above 75% is considered “sufficient for 
good clinical decision-making” but the benchmark is to reach P30 > 90% [23] 
Main results are presented stratified for mGFR below and above 75 mL/min/1.73 m2, as abnormal GFR in children 
has been regarded to start below this threshold [24], and by gender. Quantile regression with linear and quadratic 
fractional polynomials was used to model the relation between age or mGFR and the 50th percentile of eGFR-mGFR 
(i.e., median bias). Non-parametric and asymptotic 95% confidence intervals (CI) were calculated for the main 
results as measures of the statistical uncertainty in medians and proportions (P10 and P30). We used McNemar’s 
exact test for pairwise comparisons of P30 across different equations for the main results. 
In explorative analysis, we evaluated the performance of the arithmetic means of the most accurate creatinine and 
cystatin C equations compared to composite equations using a more detailed stratification of mGFR (< 30, 30-44, 
45-59, 60-74, 75-89, 90-119 and ≥ 120 mL/min/1.73 m2). 
As supplementary results, we restricted the analysis to one randomly chosen measurement per patient in order to 
obtain statistically independent observations. We also stratified results by age (2-7, 8-12 and 13-17 full years) and 
by age- and gender-specific BMI percentiles (< 5% underweight, 5 to <85% healthy weight, 85 to <95% over-
weight and ≥ 95% obese) [25] representative for Dutch children [26]. LMS values (L curve, skewness; M curve, 
median; and S curve, coefficient of variation) from reference [26] were converted into BMI percentiles via the z 
score which is calculated from Z =(y / M)L - 1 / (S x L) when L ≠ 0. The corresponding percentile was obtained 
from the standard normal distribution, e.g., z = - 1.96 corresponds to the 2.5th percentile, z = 0 to the 50th 
percentile and z = + 1.96 to the 97.5th percentile. We also present results stratified by organ transplantation and 
individual cohorts. 
Results 
Patient characteristics for the entire cohort (n = 3408 measurements) are presented in Table 1 and split by partici-
pating centres in Supplementary Material (Table S2). The proportion of organ transplant recipients was 
substantially higher in patients with mGFR below 75 mL/min/1.73 m (26 versus 4.2%). Patients with mGFR <75 
mL/min/1.73m2 tended to be older than those with mGFR ≥ 75 mL/min/1.73 m2 (median age 13.0 versus 11.9 
years), while there were no important differences in gender distribution, weight or height. There was no marked 
difference in mGFR distribution between boys and girls at any age. Boys and girls also had similar sCr and sCys 
values overall until puberty. In boys aged 13 to 17 years, however, both sCr and sCys concentrations were about 
15% higher in boys than in girls of the same age. 
 
Table 1 Patient characteristics of children 2 to < 18 years of age with descriptive measures given as median values 




(n = 3408/2218) 
mGFR 
<75 mL/min/1.73 m2 
(n = 1068/558) 
mGFR 
≥ 75 mL/min/1.73 
m2 (n = 2340/1806) 
Girls 




Girls, number (%) 1411/924 
(41/42) 
425/232 (40/42) 986/751 (42/42) NA NA 
Transplants, number (%) 378/140 
(11/6.3) 
279/99 (26/18) 99/63 (4.2/3.5) 127/49 (9.0/5.3) 251/91 
(13/7.0) 
Age (years) 12.3 (2.6-17.8) 13.0 (3.1-17.7) 11.9 (2.5-17.8) 12.0 (2.6-17.8) 12.5 (2.6-17.7) 
Weight (kg) 41 (13-86) 42 (14-86) 40 (13-86) 40 (13-80) 42 (14-88) 
Height (cm) 148 (90-184) 149 (91-183) 148 (90-185) 147 (90-176) 150 (90-186) 
Body surface area (m2) 1.31 (0.57-2.0) 1.33 (0.57-2.02) 1.29 (0.56-2.06) 1.29 (0.56-1.91) 1.33 (0.57-
2.10) 
Body mass index (kg/m2) 18 (14-29) 18 (14-31) 18 (14-29) 18 (13-29) 18 (14-30) 
Plasma creatinine µmol/L) 57 (21-189) 90 (39-328) 48 (19-91) 54 (21-179) 60 (21-201) 




90 (23-165) 56 (15-74) 103 (77-172) 90 (24-165) 91 (23-164) 
Measured GFR, number (%)                
   ≥120 mL/min/1.73 m2 607 (18) NA 607 (26) 244 (17) 363 (18) 
   90-119 mL/min/1.73 m2 1149 (34) NA 1149 (49) 485 (34) 664 (33) 
   75-89 mL/min/1.73 m2 584 (17) NA 584 (25) 257 (18) 327 (16) 
   60-74 mL/min/1.73 m2 449 (13) 449 (42) NA 176 (12) 273 (14) 
   45-59 mL/min/1.73 m2 285 (8.4) 285 (27) NA 121 (8.6) 164 (8.2) 
  30-44 mL/min/1.73 m2 185 (5.4) 185 (17) NA 75 (5.3) 110(5.5) 
  <30 mL/min/1.73 m2 149 (4.4) 149 (14) NA 53 (3.8) 96 (4.8) 




The paediatric Schwartz-LyonCR equation exhibited the best or second-best results among the creatinine equations 
in terms of bias, precision and all three accuracy measures both below and above an mGFR of 75 mL/min/1.73 m2 
(Table 2). The P30 accuracy at mGFR <75 mL/min/1.73 m2 was significantly higher than for all other creatinine 
equations (p <0.001) except for Schwartz-2012CR (p = 0.35). Schwartz-LyonCR also exhibited the most stable 
performance across the whole spectrum of mGFR, especially at the lowest and highest mGFR intervals 
(Supplementary Material and Table S3). Underestimations exceeding 20 mL/min/1.73 m were noted for Schwartz-
2012CR at mGFR >120 mL/min/1.73 m2 and for LMRCR at mGFR >130 mL/min/1.73 m2 (Fig. 1a). All creatinine 
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equations, however, had poor performance at mGFR < 30 mL/min/1.73 m2 with P30 values ≤ 60% (Supplementary 
Material and Table S3). 
CYSTATIN C EQUATIONS 
Both the general-purpose (CAPACYS, CKD-EPICYS and FASCYS) and the paediatric (BergCYS and Schwartz-2012CYS) 
cystatin C equations had P30 accuracy close to 80% at mGFR < 75 mL/min/1.73 m2 and between 84 and 89% ≥ 75 
mL/min/1.73 m2 (Table 2). However, Schwartz-2012CYS markedly underestimated mGFR ≥ 75 mL/min/1.73 m2, 
resulting in higher absolute percentage error and lower P10 compared to the other cystatin C equations. 
Underestimation exceeding 20 mL/min/1.73 m was noted for Schwartz- 2012CYS at mGFR > 120 mL/min/1.73 m2 
but also for FASCYS at mGFR > 135 mL/min/1.73 m2 (Fig. 1b). BergCYS, CAPACYS and CKD-EPICYS exhibited low bias and 
generally satisfactory accuracy across all levels of mGFR, while Schwartz-2012CYS and FASCYS had noticeably poor 
performance at mGFR <30 mL/min/1.73 m2 with P30 < 40% (Supplementary Material and Table S3). 
COMPOSITE CREATININE AND CYSTATIN C EQUATIONS 
The composite creatinine and cystatin C equations were consistently more precise than the single-marker equations 
at all mGFR levels. However, at mGFR < 75 mL/min/1.73 m2, all composite equations had a positive bias (Fig. 1c). 
Therefore, accuracy was not superior to the most accurate single-marker equations at mGFR <75 mL/min/1.73 m2 
(Table 2). All composite equations had poor P30 accuracy at mGFR <30 mL/ min/1.73 m (Supplementary Material 
and Table S3). P30 accuracy of all composite equations exceeded 90% at mGFR ≥ 75 mL/min/1.73 m2, which was 
higher than for any of the single-marker equations (Table 2). Underestimations exceeding 20 mL/min/1.73 m were 
noted for Schwartz-2012CR+CYS at mGFR > 140 mL/min/1.73 m2 (Fig. 1c). 
 
Fig. 1 Quantile regression for the relation between mGFR and median bias (50th percentile of eGFR-mGFR) in 
mL/min/1.73 m2 of a creatinine equations, b cystatin C equations and c composite creatinine and cystatin C 
equations. eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate, CAPA Caucasian, 
Asian, Paediatric and Adult equation, CKD-EPI Chronic Kidney Disease Epidemiology collaboration equation, FAS 
Full Age Spectrum equation, Ht height, LMR Lund-Malmo revised equation 
Table 2 Bias, precision and accuracy (95% confidence intervals) of GFR estimating equations based on creatinine, cystatin C and 
their combinations in children 2 to < 18 years (n = 3408 measurements) and stratified for measured GFR < 75 (n = 1068) and 







P10 (%) P30 (%) 
mGFR <75 (median 56) mL/min/1.73 m2 Creatinine 
FAS-Age  9.5 (8.5 to 10.2) 15.9 20.3 (18.8 to 22.0) 27.0 (24.3 to 29.6) 66.8 (63.9 to 69.6) 
FAS-Height 6.6 (5. To 7.2) 15.8 16.4 (15.5 to 18.0) 33.1 (30.2 to 35.9) 72.3 (69.6 to 75.0) 
LMR 13.1 (11.8 to 14.0) 19.1 25.7 (23.9 to 27.5) 22.8 (20.2 to 25.3) 56.7 (53.8 to 59.7) 
Schwartz-2009 6.9 (5.9 to 7.6) 15.1 16.7 (15.3 to17.8) 31.0 (28.2 to 33.8) 73.0 (70.4 to 75.7) 
Schwartz-2012 4.1 (3.3 to 4.7) 11.5 13.1 (12.4 to 14.0) 41.5 (38.5 to 44.4) 81.1 (78.7 to 83.4) 
Schwartz-Lyon 2.3 (1.5 to 3.1) 13.0 12.7 (12.0 to 13.7) 39.4 (36.5 to 42.4) 82.0 (79.7 to 83.4) 
Cystatin C 
Berg 1.1 (0.2 to 1.7) 13.1 13.7 (12.7 to 14.8) 37.2 (34.3 to 40.1) 81.1 (78.7 to 84.4) 
CAPA 1.1 (0.4 to 1.9) 15.2 15.4 14.3 to 16.6) 33.7 (30.9 to 36.5) 79.0 (76.6 to 81.5) 
CKD-EPI -1.1 (-1.7 to -0.5) 13.4 14.9 (13.8 to 15.9) 36.6 (33.7 to 39.5) 80.3 (78.0 to 82.7) 
FAS 4.5 (3.6 to 5.0) 12.2 14.5 (13.4 to 15.6) 36.6 (33.7 to 39.5) 77.6 (75.1 to 80.1) 
Schwartz-2012 2.4 (1.7 to 3.1) 12.4 13.3 (12.1 to 14.7) 39.7 (36.8 to 42.6) 81.6 (79.2 to 83.9) 
Creatinine+cystatin C 
FAS-AGE 6.1 (5.4 to 6.9) 10.9 15.0 (13.6 to 16.3) 37.8 (34.9 to 40.7) 77.4 (74.9 to 79.9) 
FAS-Height 4.9 (4.4 to 5.4) 11.4 13.0 (12.0 to 14.0) 39.8 (36.9 to 42.7) 81.5 (79.1 to 83.8) 
Schwartz-2012 4.4 (3.8 to 4.9) 10.6 12.9 (12.0 to 13.7) 40.9 (38.0 to 43.9) 81.9 (79.6 to 84.2) 
Andersen 4.0 (3.3 to 4.6) 11.6 12.1 11.1 to 13.1) 43.0 (40.0 to 45.9) 82.4 (80.1 to 84.7) 
mGFR ≥75 (median 103) mL/min/1.73 m2 
Creatinine 
FAS-Age 5.8 (4.6 to 6.7) 27.9 13.5 (12.9 to 14.1) 38.6 (36.7 to 40.6) 82.4 (80.8 to 83.9) 
FAS-Height 5.4 (4.3 to 6.4) 29.1 13.6 (12.7 to 14.4) 38.2 (36.2 to 40.2) 82.0 (80.4 to 83.5) 
LMR -4.1 (-5.0 to -3.1) 26.2 12.5 (11.8 to 13.3) 41.1 (39.1 to 43.1) 88.2 (86.9 to 89.5) 
Schwartz-2009 5.2 (4.1 to 6.6) 29.8 14.7 (14.1 to 15.5) 35.2 (33.2 to 37.1) 81.5 (79.9 to 83.1) 
Schwartz-2012 -13.2 (-14.0 to -12.3) 22.7 15.2 (14.6 to 16.8) 32.5 (30.6 to 34.4) 85.9 (84.4 to 87.3) 
Schwartz-Lyon -3.6 (-4.7 to -2.3) 26.0 13.5 (12.7 to 14.1) 38.8 (36.8 to 40.8) 87.1 (85.7 to 88.4) 
Cystatin C 
Berg -1.1 (-2.2 to -0.2) 28.3 13.8 (13.0 to 14.3) 38.5 (36.5 to 40.4) 83.8 (82.3 to 85.3) 
CAPA -0.4 (-1.5 to -0.6) 30.1 14.4 (13.6 to 15.0) 36.7 (34.7 to 38.6) 84.6 (83.2 to 86.1) 
CKD-EPI -1.6 (-2.6 to -0.7) 27.2 13.1 (12.5 to 13.7) 39.6 (37.6 to 41.6) 87.5 (86.1 to 88.8) 
FAS -6.2 (-7.0 to -5.4) 24.3 12.9 (12.2 to 13.7) 40.1 (38.1 to 42.1) 88.9 (87.7 to 90.2) 
Schwartz 2012 -13.3 (-14.1 to -12.3) 22.7 15.0 (14.2 to 15.6) 31.9 (30.0 to 33.8) 85.9 (84.4 to 87.3) 
Creatinine+cystatin C 
FAS-AGE -0.9 (-1.7 to -0.2) 21.2 10.2 (9.7 to 10.8) 49.2 (47.2 to 51.2) 93.4 (92.4 to 94.4) 
FAS-Height -1.2 (-2.0 to -0.5) 20.8 10.1 (9.7 to 10.6) 49.2 (47.2 to 51.3) 93.2 (92.1 to 94.2) 
Schwartz-2012 -7.0 (-7.9 to -6.3) 19.7 11.0 (10.5 to 11.6) 46.1 (44.0 to 48.1) 93.1 (92.0 to 94.1) 
Andersen -1.3 (-2.1 to -0.5) 21.7 10.8 (10.3 to 11.4) 46.8 (44.8 to 48.9) 91.4 (90.2 to 92.5) 
Median bias (eGFR - mGFR) and precision (interquartile range) expressed in mL/min/1.73 m2 and accuracy expressed as median absolute percentage 
error (100 ˙ |eGFR - mGFR|/ mGFR) and P10 and P30 accuracy (percentage of GFR estimates within ± 10 and ± 30% of mGFR). □P30 < 75%, □P30 75 to 
< 90%, □P30 ≥ 90% 
CAPA  Caucasian, Asian, Paediatric and Adult, CKD-EPI Chronic Kidney Disease Epidemiology collaboration, FAS Full Age Spectrum, LMR Lund- Malmo 
revised, eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate
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STRATIFICATION FOR GENDER 
Most creatinine equations had equal performance in girls and boys both below and above an mGFR of 75 
mL/min/1.73 m (Table 3). Notably, Schwartz-LyonCR, a modification of Schwartz-2009CR with a lower k factor (32.5 
instead of 36.5) in all girls and in boys < 13 years, performed better than Schwartz-2009CR both below and above an 
mGFR of 75 mL/ min/1.73 m2. CKD-EPICYS, the only cystatin C equation with a gender factor, exhibited equal 
performance among girls and boys both below and above mGFR 75 mL/min/1.73 m2, while the other cystatin C-
based equations had lower P30 accuracy in girls compared to boys at mGFR <75 mL/min/1.73 m (Table 3). The 
improvement in performance of the composite equations at mGFR ≥ 75 mL/min/1.73 m was noted in both boys 
and girls. 
ARITHMETIC MEANS OF CREATININE AND CYSTATIN C EQUATIONS 
In the explorative analysis, the performance of the arithmetic means of the most accurate creatinine and cystatin C 
equations was evaluated; Schwartz-LyonCR combined with BergCYS, CAPACYS or CKD-EPICYS (Supplementary Material, 
Table S3 and Fig. S1). All three performed similarly, generally with decreased bias irrespective of mGFR level and 
improved P30 accuracy below 45 mL/min/1.73 m compared to the composite equations. The P30 accuracy was equal 
or higher than for any of the three corresponding cystatin C equations at all mGFR levels ≥ 30 mL/min/1.73 m2. 
SUPPLEMENTARY RESULTS 
Restricting the analysis to one randomly chosen measurement per patient did not change overall results markedly 
but reduced statistical precision. As an example, P30 for Schwartz- LyonCR was 79.0% (95% CI 75.3 to 82.6%) among 
480 unique patients with mGFR < 75 mL/min/1.73 m2 compared with 82.0% (95% CI 79.7 to 83.4%) among all 
measurements (Table 2). Corresponding figures for 1738 unique patients with mGFR > 75 mL/min/1.73 m2 were 
85.7% (95% CI 84.0 to 87.3%) compared with 87.1% (95% CI 85.7 to 88.4%) among all measurements. 
STRATIFICATION FOR AGE 
Schwartz-LyonCR, BergCYS and CKD-EPICYS had relatively stable and adequate performance in all age groups both 
below and above mGFR of 75 mL/min/1.73 m2 (Fig. 2a-c, Supplementary Material and Table S4). The improvement 
in performance for the composite equations at an mGFR ≥ 75 mL/min/1.73m2 was seen across all age groups. The 
arithmetic means of Schwartz-LyonCR combined with BergCYS, CAPACYS or CKD-EPICYS had a stable performance across 
all age groups except for the combination with CAPA below the age of 6 years (Supplementary Material and Fig. S2). 
STRATIFICATION FOR BMI 
In general, all creatinine equations had a marked positive bias in underweight patients both below and above mGFR 
of 75 mL/min/1.73 m2, while bias of the cystatin C equations was lower (Supplementary Material and Table S5A 
and B). Despite this, none of the cystatin C equations had P30 accuracy above 75% in underweight patients at mGFR 
<75 mL/min/1.73 m2, while this was the case at mGFR > 75 mL/min/1.73 m2 and in obese patients irrespective of 
mGFR level. 
PATIENTS WITH ORGAN TRANSPLANTS 
All equations performed at least as well in transplanted as in the other patients, both at mGFR below and above 75 
mL/ min/1.73 m2 (Supplementary Material and Table S6). 
RESULTS IN INDIVIDUAL COHORTS 
Bias and P30 accuracy of the various GFR equations in the individual cohorts are presented in Supplementary 
Material (Table S7A and B). In general, the bias of the cystatin C equations varied more across the cohorts 
compared with the creatinine equations. Of note, in the Lund Cohort, all cystatin C equations had a negative bias at 
mGFR ≥ 75 mL/min/1.73 m2. The cohort from Leuven had only 16 measurements below 75 mL/min/1.73 m2 and 
these results should therefore be interpreted with caution. 
Table 3  Bias and accuracy (P30) of GFR estimating equations based on creatinine, cystatin C and their combinations 
in children 2 to < 18 years old (n = 3408 measurements) and stratified by gender and measured GFR < 75 and (n = 
1068) ≥ 75 mL/min/1.73 m2 (n = 2340)  
Equations  Creatinine Cystatin C Creatinine and cystatin C 






























mGFR <75 mL/min/1.73 m2   
Bias   
Girls 425 (40) 55 10.0 7.5 9.3 8.9 5.6 2.5 4.0 4.1 0.1 7.4 5.4 8.4 6.7 6.5 5.8 
Boys 643 (60) 56 8.9 5.5 16.0 5.1 2.3 2.1 -0.9 -0.7 -1.8 2.3 0.6 4.8 3.6 2.8 2.5 
P30 (%)   
Girls   65 73 70 71 78 83 77 74 80 72 79 72 78 78 80 
Boys   68 72 48 75 83 81 84 82 81 81 84 81 84 85 84 
mGFR ≥ 75 mL/min/1.73 m2   
Bias   
Girls 986 (42) 102 7.1 7.0 -6.4 9.3 10.6 -2.5 4.7 5.7 -0.3 -2.0 -9.1 2.2 1.6 -3.5 3.1 
Boys 1,354 
(58) 
103 4.6 4.3 -1.7 2.4 -15.1 -4.2 -5.2 -4.9 -2.6 -9.4 -16.2 -3.6 -3.4 -10.0 -4.0 
P30 (%)   
Girls   82 83 89 81 90 87 81 84 87 89 89 92 92 94 89 
Boys   83 81 88 82 83 87 86 85 88 89 84 94 94 92 93 
Median bias (eGFR - mGFR) expressed in mL/min/1.73 m and P30 accuracy as percentage of GFR estimates within ±30% of mGFR. □P30 < 75%, 
□P30 75 to < 90%, □P30 ≥ 90% 
CAPA Caucasian, Asian, Paediatric and Adult, CKD-EPI Chronic Kidney Disease Epidemiology collaboration, FAS Full Age Spectrum, LMR Lund- 
Malmô revised, eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate 
 
Fig. 2 Quantile regression for the relation between age and median bias (50th percentile of eGFR-mGFR) in 
mL/min/1.73 m2 of a creatinine equations, b cystatin C equations and c composite creatinine and cystatin C 
equations. eGFR estimated glomerular filtration rate, mGFR measured glomerular filtration rate, CAPA Caucasian, 
Asian, Paediatric and Adult equation, CKD-EPI Chronic Kidney Disease Epidemiology collaboration equation, FAS 
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Full Age Spectrum equation, Ht height, LMR Lund-Malmo revised equation 
Discussion 
Three cystatin C equations, i.e. BergCYS, CAPACYS and CKD- EPICYS, had low bias and generally satisfactory accuracy 
across all levels of mGFR. By contrast, the creatinine equations were generally hampered by substantial overestima-
tion and lack of accuracy in children with decreased renal fonction. Only the paediatric Schwartz-LyonCR equation 
had satisfactory performance at all mGFR levels ≥ 30 mL/min/1.73 m2. Arithmetic means ofthese best-performing 
creatinine and cystatin C equations generally lead to further improvement in accuracy at all mGFR levels ≥ 30 
mL/min/1.73 m2. 
The present, multi-centre study is the largest validation of GFR equations in children conducted to date. The cohort 
represents children, mainly of Caucasian descent, from several European countries and covers the age span 
between 2 and 17 full years of age, both girls and boys and with a broad spectrum of diagnoses. Therefore, the 
findings are applicable in daily clinical practice and extend beyond the populations where the various GFR 
equations were developed. Importantly, both creatinine and cystatin C were analyzed using IFCC standards at all 
participating centres. 
The varying results for the cystatin C equations across the different cohorts suggest that residual differences remain 
in calibration despite the international standard [27-29]. In the Lund cohort, all cystatin C equations had a marked 
negative bias at mGFR ≥ 75 mL/min/1.73 m2, although a meticulous technique was used to make the cystatin C 
assay traceable to the international calibrator in this cohort [7]. This may indicate that the cystatin C assays used 
when developing BergCYS, CKD-EPICYS, FASCYS and Schwartz-2012CYS were suboptimized in relation to the 
international calibrator. Although the Lund cohort was used for the development CAPACYS, it also had a marked 
negative bias. This may be explained by the fact that the Lund paediatric cohort formed only a minor part of the 
entire development cohort, which was dominated by Swedish and Japanese adults. This may have affected the 
coefficients of CAPACYS and resulted in the negative bias in children observed in our study. It should also be noted 
that roughly 20% of the included measurements were used previously in the development or internal validation of 
CAPACYS, Schwartz-LyonCR and the FAS equations, which may have favored the performance of these equations. 
Blood urea nitrogen was not available in all cohorts so that the most elaborate CKiD-3 equation [3] could not be 
tested. The choice of the arithmetic mean equations was driven by the results for the single-marker equations. This 
may have favored the performance of arithmetic means when compared to the composite creatinine-cystatin C 
equations. 
The present study adds substantial evidence suggesting that cystatin C is a more reliable filtration marker than 
creatinine for GFR estimations in children with decreased GFR. CKD-EPICYS was originally developed for adults [22] 
but nevertheless exhibited surprisingly stable performance across all levels of GFR in the present cohort of children. 
Although the CKD-EPICYS did not outperform some of the paediatric cystatin C equations with simpler formula 
expressions, it has the advantage of covering the whole age spectrum from childhood to adulthood, which may 
prove attractive for direct eGFR reporting by clinical laboratories. This also applies to CAPACYS and FASCYS, although 
overestimation was an issue with FASCYS in patients with mGFR below 45 mL/ min/1.73 m2. 
The CKD-EPICYS equation has a factor of 0.932 for females, which to some extent accounts for the lower cystatin C 
values among girls than boys during puberty at the same GFR in the present study. Gender-specific differences in 
cystatin C concentrations during puberty have also been observed by others [30, 31]. The other cystatin C equations 
do not include separate gender factors, which may explain why they generally perform less well in girls with 
decreased GFR. Based on our findings, inclusion of a—possibly age-dependent—gender factor appears to be a 
straightforward modification for some of the cystatin C- based equations, which would most likely improve their 
performance in the future. 
The best-performing creatinine equation Schwartz- LyonCR is a paediatric equation with a simplistic formulation 
based on creatinine and height only. It confirms the concept that the age dependence of creatinine can be accounted 
for in most cases by inclusion of height in the estimation, at least when mGFR is above 30 mL/min/1.73 m2. 
Schwartz-LyonCR equation uses a lower k value for boys under the age of 13 and for all girls and clearly outperforms 
Schwartz-2009CR. As the Schwartz-2009CR equation—in contrast to the original formulation of the Schwartz 
equation [32]—does not account for gender- specific differences in body composition, this suggests that gender-
specific differences in creatinine production need to be accounted for in order to assure optimal performance. 
LMRCR was originally developed for adults [20] and has been shown to outperform the CKD-EPI creatinine equation 
(CKD-EPICR) in several adult cohorts, both overall and across important subgroups [33-38]. While CKD- EPICR is 
unsuitable in children [21], the present study demonstrates that LMRCR performs quite well in children with mGFR 
75-119 mL/min/1.73 m but is unsuitable outside this range. 
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The FAS-AGECR equation was developed with the intention of covering the full age spectrum in children and adults of 
all ages irrespective of GFR level [13, 12]. This approach eliminates the discontinuous course of eGFR at the 
transition from adolescence to adulthood due to the change of equation, e.g. from a Schwartz- equation to CKD-EPI 
[39, 40]. As FAS-AGECR, like LMRCR, does not require height data, eGFR can be reported automatically by the 
laboratories. Consistent with a previous study [13], we find satisfactory bias and accuracy for all FAS equations in 
children with normal GFR but overestimation in children with decreased GFR. Validation studies in adults with CKD 
have shown substandard accuracy of the FAS equations [12, 38], however. The FASCR equation corrects for dif-
ferences in sCr levels with respect to gender (starting at adolescence), age and height. The formula assumes a 
simplistic inverse relationship between GFR and sCr/Q. While this seems to work well within a certain range of 
normal sCr values, the relation is probably more complex when sCr becomes too high. This is not surprising when 
looking at most modern GFR equations, which were built using linear regression analysis following logarithmic 
transformation [41]. In a similar way, the concept of FASCYS is based on average GFR and cystatin C for a healthy 
population. It thus seems that the FAS equations in their present form can only be recommended in patients with 
normal or mildly impaired renal function and need to be reformulated in patients with low GFR. 
Previous studies have shown improved GFR estimation performance when creatinine and cystatin C are combined 
in children [1, 3, 5, 42]. The present study extends on these results by showing that this improvement is not evident 
in children with decreased GFR when existing composite equations are applied. However, our explorative results 
suggest that improvement in performance can be obtained at most levels of mGFR if an arithmetic mean of the best- 
performing creatinine and cystatin C equations is used. This is in line with previous studies showing that the simple 
arithmetic means of existing single-marker equations tend to perform as well as more complex formulations that 
include both markers [21, 43, 44]. This approach also alerts the clinician to situations where one of the two GFR 




The present study strongly suggests that cystatin C should replace creatinine as the primary biomarker of choice 
when estimating GFR in children with moderately to severely decreased GFR. Arithmetic means of well-performing 
creatinine and cystatin C equations can be expected to improve accuracy at most mGFR levels and have practical 
advantages compared to composite equations. However, if high precision is required, e.g. in patients with severely 
decreased GFR, GFR measurement by exogenous clearance markers is recommended. EKFC and its data resources 
offer an excellent opportunity for refining GFR equations further, both among children and adults. Development of 
full-age-spectrum equations and estimation strategies that utilize both creatinine and cystatin C applicable for both 
children and adults irrespective of their GFR level would greatly facilitate direct eGFR reporting by the clinical 
laboratory and solve the problem of abrupt jumps in eGFR during the transition from child- to adulthood due to the 
changes from a paediatric to an adult GFR equation. 
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